Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Hepatology. 2010 Jul;52(1):197–203. doi: 10.1002/hep.23631

Table 4. Change in LCA levels by Baseline Characteristics.

Characteristic Minimal ΔLCA Marked ΔLCA
0.002 [(−0.14)-0.07] μmol/L
(n= 14)
0.32 (0.13-1.28) μmol/L
(n= 15)



Age, years 42.4 (20.4-49.8) 48.7 (30.7-75.5)
p-value 0.05
Female sex, n (%) 4 (29) 10 (67)
p-value 0.04
BMI 27.4 (23.8-33.1) 26.5 (20.6-38.8)
p-value 0.71
Colectomy, n (%) 4 (29) 3 (20)
p-value 0.58
Histologic stage≥2, n (%) 11 (79) 10 (67)
p-value 0.66
Alkaline phosphatase* 3.5 (1.2-12.1) 4.7 (1.41-12.5)
p-value 0.34
Aspartate aminotransferase* 1.6 (0.8-3.8) 2.2 (0.7-4)
p-value 0.94
Bilirubin, mg/dL* 0.7 (0.3-2) 0.8 (0.4-2)
p-value 0.74
Mayo risk score −0.24 [(−0.67)-1.8] 0.36 [(−1.05)-1.5]
p-value 0.31

Data are presented as the median (range) unless otherwise indicated. ΔLCA= lithocholic acid after treatment-lithocholic acid at entry BMI= Body Mass Index

*

Values represent multiples of the upper limits of normal.